ApprovalTrail

Approval · Notice of Compliance 27930 · 2022

TORADOL: Notice of Compliance 27930

Issued April 6, 2022

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
27930
Date
April 6, 2022
Company
AA Pharma Inc.Toronto, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Safety Update to the Product Monograph as per advisement letter and PM migration to 2020 PM format

Products in this notice

BrandDINStatus today
TORADOLNot yet assigned—

Medicinal ingredients